drugset / Trial / NCT01071122

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

NCT01071122 ↗

Phase 4 Completed 365 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether the combination of nifedipine GITS and valsartan is more effective in reducing central blood pressure than nifedipine GITS or valsartan alone, and to determine whether nifedipine GITS is comparable to valsartan

Timeline

Start
2010-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nifedipine Other / unclassified 30 mg —
Comparator Nifedipine Other / unclassified 60 mg —
Comparator Valsartan Unknown 80 mg —
Comparator Valsartan Unknown 160 mg —